NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,409,316 | -18.3% | 445,986 | 0.0% | 0.01% | -23.1% |
Q2 2023 | $1,725,966 | +30.8% | 445,986 | -6.4% | 0.01% | +8.3% |
Q1 2023 | $1,319,708 | +53.9% | 476,429 | 0.0% | 0.01% | +33.3% |
Q4 2022 | $857,572 | -15.1% | 476,429 | 0.0% | 0.01% | -25.0% |
Q3 2022 | $1,010,000 | -24.3% | 476,429 | -3.9% | 0.01% | -20.0% |
Q2 2022 | $1,334,000 | -38.0% | 495,986 | 0.0% | 0.02% | -37.5% |
Q1 2022 | $2,153,000 | -16.2% | 495,986 | 0.0% | 0.02% | -20.0% |
Q4 2021 | $2,569,000 | -15.6% | 495,986 | 0.0% | 0.03% | -21.1% |
Q3 2021 | $3,045,000 | -77.5% | 495,986 | -65.0% | 0.04% | -75.6% |
Q2 2021 | $13,520,000 | – | 1,415,639 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 16,298,006 | $43,842,000 | 30.79% |
Madrona Venture Group, LLC | 6,020,770 | $16,196,000 | 7.52% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $3,647,000 | 3.82% |
Ally Bridge Group (NY) LLC | 1,080,566 | $2,907,000 | 2.65% |
Tikvah Management LLC | 1,488,895 | $4,005,000 | 1.73% |
ArchPoint Investors | 1,449,551 | $3,899,000 | 1.54% |
Perceptive Advisors | 9,111,151 | $24,508,000 | 0.77% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $5,380,000 | 0.63% |
CROWN ADVISORS MANAGEMENT, INC. | 250,000 | $672,000 | 0.62% |
Affinity Asset Advisors, LLC | 466,607 | $1,255,000 | 0.53% |